跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20 条关于
“retinopathies”
全部
20
临床试验
5
药物
0
机构
0
资讯
15
去年
Ocugen's OCU410ST Receives Orphan Drug Designation from EMA for ABCA4 Retinopathies
去年
Ocugen's OCU410ST Receives EMA Orphan Drug Designation for ABCA4-Associated Retinopathies
去年
Ocugen's OCU410ST Receives EMA Orphan Drug Designation for ABCA4-Associated Retinopathies
去年
EMA Grants Orphan Drug Designation to Ocugen's OCU410ST for ABCA4-Associated Retinopathies
去年
Ascidian Therapeutics Advances RNA Exon Editing Platform with Key Leadership Appointments and Clinical Progress
去年
Ocugen's OCU410ST Receives EMA Orphan Designation for Stargardt Disease
去年
Ocugen's OCU410ST Receives EMA Orphan Drug Designation, Shows Promise in Stargardt Disease
去年
Formycon's Ranivisio Becomes First Lucentis Biosimilar Approved in Brazil
9个月前
EMA Approves Seven New Medicines Including COVID-19 Vaccine and Cancer Treatments
去年
EMA Grants First-Ever Orphan Drug Designation for Radiation Maculopathy Treatment
第 1 页,共 2 页
上一页
下一页